MoneyWorks4Me

Phaarmasia - Quaterly Results

14 Feb 2025 Evaluate
The sales is pegged at Rs. 47.22 millions for the December 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 50.84 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -7.00 millions as compared to Net Loss of Rs. -5.65 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 further decreased to -6.04% as compared to -4.33% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 47.22 50.84 -7.12 189.39 206.05 -8.09 305.93 274.90 11.29
Other Income 1.90 1.25 52.00 5.63 4.67 20.56 6.62 5.16 28.29
PBIDT -6.04 -4.33 39.49 -8.36 -6.85 22.04 -1.58 -10.26 -84.60
Interest 0.08 0.25 -68.00 0.14 0.39 -64.10 0.44 0.45 -2.22
PBDT -6.12 -4.58 33.62 -8.50 -7.24 17.40 -2.02 -10.71 -81.14
Depreciation 0.82 0.84 -2.38 2.41 2.58 -6.59 3.44 3.60 -4.44
PBT -6.94 -5.42 28.04 -10.91 -9.82 11.10 -5.46 -14.31 -61.84
TAX 0.06 0.23 -73.91 -0.26 0.10 -360.00 -0.28 -1.73 -83.82
Deferred Tax 0.06 0.23 -73.91 -0.26 0.10 -360.00 -0.28 -1.73 -83.82
PAT -7.00 -5.65 23.89 -10.65 -9.92 7.36 -5.18 -12.58 -58.82
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -12.79 -8.52 50.19 -4.41 -3.32 32.78 -0.52 -3.73 -86.16
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..